期刊文献+

CD80-链亲和素融合蛋白锚定的鼻咽癌CNE2细胞增强T细胞的杀伤活性 被引量:1

CD80-streptavidin-decorated CNE2 cells enhance cytotoxicity of T cells
下载PDF
导出
摘要 目的:制备CD80-链亲和素(streptavidin,SA)融合蛋白,研究CD80-SA锚定的鼻咽癌CNE2细胞对T细胞杀伤活性的影响。方法:pET21a-CD80-SA-6His质粒转化大肠杆菌BL21(DE3),IPTG诱导CD80-SA融合蛋白的表达,经Ni-NTA亲和层析纯化后透析复性。流式细胞仪检测CD80-SA融合蛋白在CNE2细胞表面的锚定效率;LDH释放法检测CD80-SA锚定的CNE2细胞对T细胞杀伤活性的影响。结果:成功制备和纯化了CD80-SA融合蛋白。CNE2细胞表面低表达CD80分子[(2.2±0.18)%]。CD80-SA融合蛋白可有效地锚定于生物素化的CEN2细胞表面,锚定效率可达73%。CD80-SA锚定的CNE2细胞可有效激活T细胞的杀伤作用,效靶比在1∶1、1∶20、1∶40时T细胞的杀伤率分别约为(37±3.12)%、(51±2.63)%和(58±2.47)%,均显著高于对照CNE2细胞激活的T细胞(均P<0.01)。结论:CD80-SA融合蛋白可有效锚定于生物素化的CNE2细胞表面,从而增强T细胞对CNE2细胞的杀伤活性。 Objective:To prepare CD80-streptavidin(CD80-SA)fusion protein and immobilize it on the surface of nasopharyngeal carcinoma CNE2 cells(CD80-SA-CNE2 cells),so as to investigate the effect of CD80-SA-CNE2 cells on cytotoxicity of T cells.Methods:pET21a-CD80-SA-6His expression plasmid was transformed into E.coli BL21(DE3).The CD80-SA fusion protein was induced by IPTG,purified by Ni-NTA affinity chromatography and refolded by dialysis.The immobilization rate of CD80-SA on CNE2 cell surface was analyzed by flow cytometry,and the effect of CD80-SA-CNE2 cells on cytotoxicity of T cells was detected by LDH assay.Results:CD80-SA fusion protein was successfully prepared and purified.CD80 was lowly expressed on CNE2 cells([2.233±0.176]%).CD80-SA fusion protein was effectively immobilized on the surface of biotinylated-CNE2 cells,with the immobilization rate being 73%.Moreover,CD80-SA-CNE2 cells effectively induced cytotoxicity of T cells;the cytotoxic rates of T cells were(37±3.12)%,(51±2.63)% and(58±2.47)% at the E∶T ratios of 1∶1,1∶20 and 1∶40,respectively,which were significantly higher than those of control CNE2 cells(all P〈0.01).Conclusion:CD80-SA fusion protein can be effectively immobilized on the surface of biotinylated-CNE2 cells,enhancing the cyctotoxicty of T cells against CNE2 cells.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2010年第4期398-402,共5页 Chinese Journal of Cancer Biotherapy
基金 国家高技术研究发展计划(863计划)资助项目(No.2006AA02Z4C4) 广州市白云区科技计划资助项目(No.2009-SZ-40)~~
关键词 CD80 链亲和素 生物素 融合蛋白 鼻咽癌细胞 T细胞 杀伤 CD80 streptavidin biotin fusion protein nasopharyngeal carcinoma cell T cell cytotoxicty
  • 相关文献

参考文献23

  • 1Greenberg PD. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells [J].Adv hnmunol, 1991,49 : 281-355.
  • 2Martin-Fontecha A, Moro M, Crosti MC, Veglia F, Casorati G, Dellabona P. Vaccination with mouse mammary adenocarcinoma cells coexpressing B7-1 ( CD80 ) and B7-2 ( CD86 ) discloses the dominant effect of B7-1 in the induction of antitumor immunity [J]. J Immunol, 2000, 164(2) : 698-704.
  • 3Leitner J, Grabmeier-Pfistershammer K, Stelnberger P. Receptors and ligands implicated in human T cell costimulatory processes [J]. Immunol Lett, 2010, 128(2) : 89-97.
  • 4Seliger B, Marincola FM, Ferrone S, Abken H. The complex role of B7 molecules in tumor immunology [ J]. Trends Mol Med, 2008, 14(12) : 550-559.
  • 5Driessens G, Kline J, Gajewski TF. Costimulatory and coinhibitory receptors in anti-tumor immunity [J].Immunol Rev, 2009, 229 ( 1 ) : 126-144.
  • 6Quesnel B. Tumor dormancy and immune escape [ J]. APMIS. 2008, 116(7-8) : 685-694.
  • 7Peggs KS, Quezada SA, Allison JP. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy[J]. hnmunol Rev, 2008, 224 : 141-165.
  • 8Gao J, Huang S, Li M, Luo R, Wang X, Takashima A. GM- CSF-surface-modified B16. FI1 melanoma cell vaccine [ J ]. Vaccine, 2006, 24(25): 5265-5268.
  • 9Yuan S, Shi C, Lv Y, Wang T, Wang H, Han W. A novel Bacillus Calrrvette-Gudrin-based breast cancer vaccine that coexpresses multiple tandem repeats of MUC1 and CD80 breaks the immune tolerance and inhibits MUCI -positive breast cancer growth [ J ]. Cancer B iother Radiopharm, 2009, 24 ( 5 ) : 607-613.
  • 10Todo T, Martuza RL, Dallman MJ, Rabkin SD. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent anti-tumor immunity [ J]. Cancer Res, 2001, 61 (1) : 153-161.

二级参考文献35

共引文献12

同被引文献20

  • 1Sano T, Cantor CR. Streptavidin-containing chimeric proteins: Design and production [ J]. Methods Enzymol, 2000, 326: 305- 311.
  • 2Gao J, Huang S, Li M, et al. GM-CSF-surface-modified B16. FIO melanoma cell vaccine [ J ]. Vaccine, 2006, 24 (25) : 5265- 5268.
  • 3Alderson MR, Sassenfeld HM, Widmer MB. Interleukin 7 en- hances cytolytic T lymphocyte generation and induces lymphokine- activated killer cells from human peripheral blood [J]. Int J Clin Exp Med, 1990, 172(2) : 577-587.
  • 4Saini M, Pearson C, Seddon B. Regulation of T cell-dendr/tic cell interactions by IL-7 governs T-cell activation and homeostasis [J]. Blood, 2009, 113(23) : 5793-5800.
  • 5Pellegrini M, Calzascia T, Elfon] AR, et al. Adjuvant IL-7 antag- onizes multiple cellular and molecular inhibitory networks to en- hance immunotherapies [ J]. Altern Med Rev, 2009, 15 (5) :528-536.
  • 6Fry TJ, Mackall CL. Interleukin-7: From bench to clinic [ J]. Blood, 2002, 99 ( 11 ) : 3892-3904.
  • 7Li B, Vanroey M J, Jooss K. Recombinant IL-7 enhances the po- tency of GM-CSF-secreting tumor cell immunotherapy [J]. Aller- gy Asthma Clin Immunol, 2007, 123(2) : 155-165.
  • 8Zhang Z, Xu X, Zhang X, et al. The therapeutic potential of SA- sCIMOL in the orthotopic model of superficial bladder cancer [J]. ActaOncol, 2011, 50(7): 1111-1118.
  • 9Kaufman DS, Shipley W, Feldman AS. Bladder cancer [ J]. Lan- cet, 2009, 374(9685): 239-249.
  • 10Kausch I, Doehn C, Jocham D. Recent improvements in the detec- tion and treatment of nonmuscle-invasive bladder cancer [ J]Ex- pert Rev Anticancer Ther, 2006, 6(9) : 1301-1311.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部